Myopathy in older people receiving statin therapy: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2015-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/bcp.12687PMID 26032930PMCID PMC4574822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An assessment by the Statin Muscle Safety Task Force: 2014 update.

  2014cited by this paper
• Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis

  2014cited by this paper
• Intolerance to Statins: Mechanisms and Management

  2013cited by this paper
• The Cochrane collaboration's tool for assessing risk of bias

  2013cited by this paper
• Muscular effects of statins in the elderly female: a review

  2013cited by this paper
• SLCO1B1 Polymorphisms and Statin-Induced Myopathy

  2013cited by this paper
• The spectrum of statin myopathy

  2013cited by this paper
• Effect of Statins on Skeletal Muscle: Exercise, Myopathy, and Muscle Outcomes

  2012cited by this paper
• Statin induced myotoxicity.

  2012cited by this paper
• The controversies of statin therapy: weighing the evidence.

  2012cited by this paper
• Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users.

  2012cited by this paper
• Statin myopathy: A common dilemma not reflected in clinical trials

  2011cited by this paper
• The Problem of Subgroup Analyses: An Example from a Trial on Ruptured Intracranial Aneurysms

  2011cited by this paper
• The Risk for Significant Creatine Kinase Elevation with Statins

  2010cited by this paper
• Effects of Statins on Skeletal Muscle: A Perspective for Physical Therapists

  2010cited by this paper
• Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

  2010cited by this paper
• Cochrane Handbook for Systematic Reviews of Interventions

  2010cited by this paper
• Statin therapy in the elderly: a review.

  2010cited by this paper
• Narrative Review: Statin-Related Myopathy

  2009cited by this paper
• Management of Hyperlipidemia in Older Adults

  2009cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2009cited by this paper
• Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

  2008cited by this paper
• Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE)

  2007cited by this paper
• Rosuvastatin in older patients with systolic heart failure.

  2007cited by this paper
• Efficacy and safety of statin monotherapy in older adults: a meta-analysis.

  2007cited by this paper
• Pharmacokinetic-Pharmacodynamic Crisis in the Elderly

  2007cited by this paper
• Statin safety: a systematic review.

  2006cited by this paper
• Statin-related adverse events: a meta-analysis.

  2006cited by this paper
• Preliminary experience with the use of oral linezolid in infants for the completion of antibiotic therapy in the outpatient setting after admission to the pediatric intensive care unit.

  2006cited by this paper
• Overcoming ‘Ageism’ Bias in the Treatment of Hypercholesterolaemia

  2006cited by this paper
• Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study

  2005cited by this paper
• Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

  2005cited by this paper
• Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors☆

  2004cited by this paper
• Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

  2004cited by this paper
• Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.

  2004cited by this paper
• Current overview of statin-induced myopathy.

  2004cited by this paper
• Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

  2004cited by this paper
• Issues in Subgroup Analyses and Meta‐Analyses of Clinical Trials

  2003cited by this paper
• Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

  2003cited by this paper
• The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention.

  2003cited by this paper
• Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events.

  2003cited by this paper
• Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001cited by this paper
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

  2000cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Meta-analysis: Principles and procedures

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.

  1995cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Inhalation of levomepromazine in severe acute asthma.

  1994cited by this paper
• Simvastatin in the treatment of elderly patients with primary hypercholesterolemia

  1994cited by this paper
• Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients.

  1993cited by this paper
• Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.

  1991cited by this paper

• Ageing of human myofibres in the Vastus Lateralis muscle: a narrative review.

  2026cites this paper
• Rhabdomyolysis

  2025cites this paper
• Assessing the impact of frailty on statin prescriptions among older stroke survivors with and without diabetes in Malaysia

  2025cites this paper
• Managing hypertension, diabetes, and dyslipidemia in frail older adults

  2025cites this paper
• Uncovering protein prenylation in Th1 cells: novel prenylation sites and insights into statin and farnesyltransferase inhibition

  2025cites this paper
• Lipitension today — disaster tomorrow: focus on elderly comorbid patients

  2025cites this paper
• Nurse-led secondary preventive follow-up after stroke/TIA and ACS for patients aged 80 years or older: A post-hoc analysis of the randomized controlled NAILED trial

  2025cites this paper
• Exercise-Induced Rhabdomyolysis - Case Study

  2024cites this paper
• Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients with Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic

  2024cites this paper
• Treating Hypercholesterolemia in Older Adults for Primary Prevention of Cardiovascular Events

  2024cites this paper
• The role of statin therapy in older adults: best practices and unmet challenges

  2024influential citation
• Benefits and Risks Associated With Statin Therapy for Primary Prevention in Old and Very Old Adults

  2024cites this paper
• Statin-Associated Liver Dysfunction and Muscle Injury: epidemiology, Mechanisms, and Management Strategies

  2024cites this paper
• Low-Density Lipoprotein Cholesterol-Lowering Drugs: A Narrative Review

  2024cites this paper
• Management of dyslipidemia in older adults

  2023cites this paper
• Developing In Vitro Models to Define the Role of Direct Mitochondrial Toxicity in Frequently Reported Drug-Induced Rhabdomyolysis

  2023cites this paper
• Drug safety signal detection in a regional healthcare database using the tree‐based scan statistic and comparison to 3 other mining methods

  2023cites this paper
• Necrotizing Autoimmune Myopathy: A Case Report on Statin-Induced Rhabdomyolysis

  2023cites this paper
• European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication.

  2023cites this paper
• Changes in cholesterol homeostasis associated with aging and with age-related conditions: pathophysiological and clinical implications

  2023cites this paper
• Statin Induced Myopathy Among Patients Attending the National Center for Diabetes, endocrinology, & genetics

  2022cites this paper
• Proximal myopathy: causes and associated conditions

  2022cites this paper
• Primary prevention statin therapy in older adults

  2022cites this paper
• Lipid‐lowering treatment among older patients with atherosclerotic cardiovascular disease

  2022cites this paper
• Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials

  2022cites this paper
• Associations between statins and adverse events in secondary prevention of cardiovascular disease: Pairwise, network, and dose-response meta-analyses of 47 randomized controlled trials

  2022cites this paper
• Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome.

  2022cites this paper
• Age‐Related Associations of Low‐Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population‐Based Cohort Study

  2022cites this paper
• Lipid-Targeted Atherosclerotic Risk Reduction in Older Adults: A Review

  2022cites this paper
• Drug–Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data

  2022cites this paper
• Fatal rhabdomyolysis and disseminated intravascular coagulation after total knee arthroplasty under spinal anesthesia: A case report

  2022cites this paper
• Do medicines commonly used by older adults impact their nutrient status?

  2021cites this paper
• Risk Factors Associated with Statin-Associated Muscle Symptoms in Patients Attending a Specialized Regional Lipid Clinic

  2021cites this paper
• Schlaganfalltherapie im Alter

  2021cites this paper
• Severe rhabdomyolysis induced by co-administration of cocaine and heroin in a 45 years old man treated with rosuvastatin: a case report

  2021cites this paper
• Statin (mis)use in older people: A cross‐sectional study using French health insurance databases

  2021cites this paper
• Atorvastatin-Induced Myalgia in Iranian Patients: A Hospital-Based Study to Determine the Prevalence and Associated Risk Factors

  2021cites this paper
• Pharmacological Management of Hyperlipidemia in Older individuals.

  2021cites this paper
• Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies

  2021cites this paper
• Never too old for lipid-lowering therapy.

  2021cites this paper
• Simvastatin Influences Selected Aspects of Duchenne Muscular Dystrophy Pathology in a Mouse Model

  2021cites this paper
• Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy

  2021cites this paper
• Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk

  2021cites this paper
• A multistate transition model for statin‐induced myopathy and statin discontinuation

  2021cites this paper
• Effect of frailty on initiation of statins following incident acute coronary syndromes in patients aged ≥75 years.

  2021cites this paper
• Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy

  2021cites this paper
• Statin Therapy in Very Old Patients: Lights and Shadows

  2021cites this paper
• Statin therapy for primary cardiovascular prevention in older adults over 75 years.

  2021cites this paper
• Statins for primary prevention among elderly men and women.

  2021cites this paper
• The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: A Personalized Approach to Risk Reduction

  2020cites this paper
• Clinical Pharmacology of Statins: an Update

  2020cites this paper
• Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

  2020cites this paper
• Iatrogenesis and neurological manifestations in the elderly.

  2020cites this paper
• The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis

  2020cites this paper
• Primary Prevention Statins in Older Adults: Personalized Care for a Heterogeneous Population

  2020cites this paper
• An overview of statin-induced myopathy and perspectives for the future

  2020cites this paper
• Utilisation de statines et maladie veineuse thrombo-embolique : une étude cas-contrôle chez des patients âgés de 75 ans et plus

  2020cites this paper
• , , RHABDOMYOLYSIS - INDUCED ACUTE KIDNEY INJURY - AN UNDERESTIMATED PROBLEM.

  2020cites this paper
• Statin intolerance: an updated, narrative review mainly focusing on muscle adverse effects

  2020cites this paper
• Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

  2020cites this paper
• Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial

  2019cites this paper
• The Role of Vascular Aging in Atherosclerotic Plaque Development and Vulnerability.

  2019cites this paper
• Management of high cholesterol levels in older people

  2019cites this paper
• Cardiovascular Disease in Older Adults

  2019cites this paper
• Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle.

  2019cites this paper
• Targeting angiogenesis in Duchenne muscular dystrophy

  2019cites this paper
• Peripheral Nervous System and Vascular Disorders Affecting Mobility in Older Adults

  2019cites this paper
• An evidence‐based narrative review of the emergency department evaluation and management of rhabdomyolysis

  2019cites this paper
• Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

  2019cites this paper
• Reaction time in healthy elderly is associated with chronic low‐grade inflammation and advanced glycation end product

  2018cites this paper
• The Study of Rhabdomyolysis in the Elderly: An Epidemiological Study and Single Center Experience

  2018cites this paper
• Association between statin use and physical function among community‐dwelling older Japanese adults

  2018cites this paper
• A cross sectional observational study to find the difference in occurrence of muscle related adverse effects of statins among geriatric and non-geriatric patients

  2018influential citation
• Dyslipidaemia in the elderly: to treat or not to treat?

  2018cites this paper
• Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry

  2018cites this paper
• A comprehensive review and meta-analysis of risk factors for statin-induced myopathy

  2018cites this paper
• Prevención primaria con estatinas en los ancianos

  2018cites this paper
• Primary Prevention With Statins in the Elderly.

  2018cites this paper
• Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management.

  2017cites this paper
• Statin therapy in the frail elderly: A nuanced decision

  2017cites this paper
• Management of Atherosclerotic Cardiovascular Disease Risk Factors in the Older Adult Patient With Diabetes

  2017cites this paper
• Clinoptilolite for Treatment of Dyslipidemia: Preliminary Efficacy Study

  2017cites this paper
• Intervention Effects of Atorvastatin Combined with Panax notoginseng Saponins on Rats with Atherosclerosis Complicated with Hepatic Injury

  2017cites this paper
• Investigating patient narratives posted on Internet and their informativeness level for pharmacovigilance purpose: The example of comments about statins.

  2017cites this paper
• Dyslipidemia Management for Elderly People with Metabolic Syndrome: A Mini-Review

  2017cites this paper
• Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function

  2017cites this paper
• Statins in cardiovascular prevention in the oldest-old. A black hole

  2017cites this paper
• The effect of lipophilicity and dose on the frequency of statin‐associated muscle symptoms: A systematic review and meta‐analysis

  2017cites this paper
• Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials

  2017cites this paper
• Running title : Goal-inhibiting statin intolerance

  2016cites this paper
• [Statin and cardiovascular diseases after 75 years].

  2016cites this paper
• Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016).

  2016cites this paper
• Safe use of statins: focus on muscle toxicity

  2016cites this paper
• Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice

  2016cites this paper
• Can treatment with statins have a negative influence on the tolerance of mandibular advancement devices?

  2016cites this paper
• Pitavastatin and carbohydrate metabolism: what is the evidence?

  2016cites this paper
• Secondary cardiovascular prevention in older adults: an evidence based review

  2015cites this paper
• Management of Dyslipidemia in the Elderly

  2014cites this paper